892491-69-9

Upstream product

• 5781-53-3 monomethyl oxalyl chloride 
• 892491-68-8 trans-[4-(4-aminophenyl)cyclohexyl]acetic acid methyl ester 
• 701232-66-8 [4-(4-hydroxyphenyl)cyclohexylidene]acetic acid methyl ester 
• 701232-67-9 trans-[4-(4-hydroxyphenyl)cyclohexyl]acetic methyl ester 
• 701232-68-0 (trans)-methyl 2-(4-(4-(((trifluoromethyl)sulfonyl)oxy)phenyl)cyclohexyl)acetate 
• 959861-91-7 C₂₈H₂₉NO₂ 
• 105640-07-1 4-(4-hydroxyphenyl)cyclohexan-1-one 

Downstream Products

• 959938-91-1 trans-methyl 2-[4-[4-[(methoxycarbonylformyl)amino]-3-nitro-phenyl]cyclohexyl]-acetate 
• 959938-92-2 methyl [trans-4-(4-{[hydrazino(oxo)acetyl]amino}-3-nitrophenyl)cyclohexyl]acetate 
• 892489-52-0 (trans-4-{4-[({5-[(3,4-difluorophenyl)amino]-1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl)acetic acid 

Relevant academic research and scientific papers

CRYSTALLINE FORM OF (TRANS-4- [ ( { 5- [ (3, 4 -DI FLUOROPHENYL) AMINO] -1,3, 4-OXADIAZOL-2-YL}CARBONYL) AMINO] PH ENYL } CYCLOHEXYL) ACETIC ACID

Novel crystalline forms of the compound (trans-4- {4-[({5-[(3,4-difluorophenyl)amino]- 1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl)acetic acid are provided, together with processes for the manufacture of such forms, pharmaceutical compositions c

BENZIMIDAZOLES AND THEIR USE FOR THE TREATEMNT OF DIABETES

Compounds of formula (I), or salts thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, (A chemical formula should be inserted here - please see paper copy enclosed herewith) (I) wherein: Rsup